loadpatents
name:-0.018517971038818
name:-0.013437032699585
name:-0.011687040328979
ASHIDA; Shinji Patent Filings

ASHIDA; Shinji

Patent Applications and Registrations

Patent applications and USPTO patent grants for ASHIDA; Shinji.The latest application filed is for "antibody-pyrrolobenzodiazepine deprivative conjugate".

Company Profile
13.16.21
  • ASHIDA; Shinji - Tokyo JP
  • Ashida; Shinji - Yao JP
  • ASHIDA; Shinji - Yao-shi JP
  • Ashida; Shinji - Chiba JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibody-pyrrolobenzodiazepine Deprivative Conjugate
App 20220168440 - TODA; Narihiro ;   et al.
2022-06-02
X-ray diagnostic apparatus
Grant 11,344,270 - Ashida , et al. May 31, 2
2022-05-31
Antibody-pyrrolobenzodiazepine Derivative Conjugate
App 20220125943 - TODA; Narihiro ;   et al.
2022-04-28
Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate
Grant 11,261,261 - Naito , et al. March 1, 2
2022-03-01
(Anti-HER2 antibody)-drug conjugate
Grant 11,185,594 - Naito , et al. November 30, 2
2021-11-30
Antibody-drug conjugate
Grant 10,973,924 - Masuda , et al. April 13, 2
2021-04-13
Method Of Treating Cancer Comprising Administration Of Anti-her2 Antibody-drug Conjugate
App 20200385486 - NAITO; Hiroyuki ;   et al.
2020-12-10
Antibody-drug Conjugate
App 20200282073 - MASUDA; Takeshi ;   et al.
2020-09-10
Antibody-pyrrolobenzodiazepine Derivative Conjugate
App 20200261594 - TODA; Narihiro ;   et al.
2020-08-20
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
Grant 10,729,782 - Naito , et al.
2020-08-04
X-ray Diagnostic Apparatus
App 20200205762 - ASHIDA; Shinji ;   et al.
2020-07-02
X-ray diagnostic apparatus
Grant 10,610,180 - Ashida , et al.
2020-04-07
Anti-her2 Antibody-drug Conjugate
App 20190077880 - NAITO; Hiroyuki ;   et al.
2019-03-14
Antibody-drug conjugate
Grant 10,195,288 - Masuda , et al. Fe
2019-02-05
Antibody-drug Conjugate
App 20190008981 - Masuda; Takeshi ;   et al.
2019-01-10
Anti-HER2 antibody-drug conjugate
Grant 10,155,821 - Naito , et al. Dec
2018-12-18
Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure
App 20180071403 - NAITO; Hiroyuki ;   et al.
2018-03-15
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
Grant 9,872,924 - Naito , et al. January 23, 2
2018-01-23
Antibody-drug conjugate
Grant 9,808,537 - Masuda , et al. November 7, 2
2017-11-07
(anti-her2 Antibody)-drug Conjugate
App 20170035906 - NAITO; Hiroyuki ;   et al.
2017-02-09
Anti-her2 Antibody-drug Conjugate
App 20160333112 - NAITO; Hiroyuki ;   et al.
2016-11-17
Antibody-drug Conjugate
App 20160279259 - Masuda; Takeshi ;   et al.
2016-09-29
Antibody-drug Conjugate Produced By Binding Through Linker Having Hydrophilic Structure
App 20150352224 - NAITO; Hiroyuki ;   et al.
2015-12-10
X-ray Diagnostic Apparatus
App 20150325011 - ASHIDA; Shinji ;   et al.
2015-11-12
Antibody-drug Conjugate
App 20150297748 - MASUDA; Takeshi ;   et al.
2015-10-22
Piperazinyl cyclohexane compounds as GPR38 agonists
Grant 9,051,255 - Toda , et al. June 9, 2
2015-06-09
Cyclohexane Derivative Compound
App 20140221391 - Toda; Narihiro ;   et al.
2014-08-07
Cyclohexane Derivative Compound
App 20140221392 - Toda; Narihiro ;   et al.
2014-08-07
Piperazinyl methyl phenyl cyclohexane compound
Grant 8,710,060 - Toda , et al. April 29, 2
2014-04-29
Cyclohexane Derivative Compound
App 20130289048 - Toda; Narihiro ;   et al.
2013-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed